Andercan
Andercan, licence 80102845: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Ginsentinib, Panaxsen
- Licence holder
- ADV. GINSEN WELLNESS LTD.
- NPN or DIN-HM
- 80102845
- Status
- Active licence
- Licence date
- 17 July 2020
- Revision date
- Not provided
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Poly(éthylène glycol), Poloxamère 188
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 5.0 Pilule | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine as an adaptogen to help maintain a healthy immune system. Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Traditionally used in Herbal Medicine to help relieve nervous dyspepsia/to help digestion in cases of nervousness and/or stress.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood thinners or digoxin.
Source
Official Health Canada record, licence 80102845
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.